A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer
Clinical trial NCT03509636 · COMPLETED
Trial details
- NCT number
- NCT03509636
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-04
- Primary completion
- 2019-08-26
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.